Daewoong to step up OTC business

Published: 2008-04-29 06:57:00

Updated: 2008-04-29 06:57:00

As pharmaceutical companies are competing to take a bigger stake in the domestic OTC market, Daewoong Pharm is activating its OTC business unit by separating it from ethical business unit.

“We are separating the two business units with high hopes of greater sales in OTCs,” said a company offic...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK